Yttrium-90 TOF-PET-Based EUD Predicts Response Post Liver Radioembolizations Using Recommended Manufacturer FDG Reconstruction Parameters

Yttrium-90 TOF-PET-Based EUD Predicts Response Post Liver Radioembolizations Using Recommended Manufacturer FDG Reconstruction Parameters

PurposeExplaining why 90Y TOF-PET based equivalent uniform dose (EUD) using recommended manufacturer FDG reconstruction parameters has been shown to predict response.MethodsThe hot rods insert of a Jaszczak deluxe phantom was partially filled with a 2.65 GBq 90Y - 300ml DTPA water solution resulting...

Full description

Bibliographic Details
Main Authors:	Michel Hesse, Philipe d’Abadie, Renaud Lhommel, Francois Jamar, Stephan Walrand
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-10-01
Series:	Frontiers in Oncology
Subjects:	radioembolization TOF-PET EUD dose-response reconstruction
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2021.592529/full

Similar Items

TCP post-radioembolization and TCP post-EBRT in HCC are similar and can be predicted using the in vitro radiosensitivity
by: Philippe d’Abadie, et al.
Published: (2022-07-01)

Microspheres Used in Liver Radioembolization: From Conception to Clinical Effects
by: Philippe d’Abadie, et al.
Published: (2021-06-01)

Optimization of the Clinical Effectiveness of Radioembolization in Hepatocellular Carcinoma with Dosimetry and Patient-Selection Criteria
by: Philippe d’Abadie, et al.
Published: (2022-03-01)

Hepatic Arterial Buffer Response in Liver Radioembolization and Potential Use for Improved Cancer Therapy
by: Stephan Walrand, et al.
Published: (2021-03-01)

A Theranostic Approach in SIRT: Value of Pre-Therapy Imaging in Treatment Planning
by: Philippe d’Abadie, et al.
Published: (2022-12-01)

Segmental Yttrium-90 Radioembolization as an Initial Treatment for Solitary Unresectable HCC
by: Natalie J. Rothenberger, et al.
Published: (2022-07-01)

Radioembolization and the dynamic role of 90Y PET/CT
by: Alexander S Pasciak, et al.
Published: (2014-02-01)

Yttrium-90 Radioembolization as the Major Treatment of Hepatocellular Carcinoma
by: Yu CY, et al.
Published: (2023-01-01)

Yttrium-90 Microsphere Radioembolization for Treatment of Lung Cancer Hepatic Metastases
by: Ron C. Gaba, et al.
Published: (2012-08-01)

Modeling the Synergistic Impact of Yttrium 90 Radioembolization and Immune Checkpoint Inhibitors on Hepatocellular Carcinoma
by: Minah Kang, et al.
Published: (2024-01-01)

Radiation pneumonitis following Yttrium-90 radioembolization: A Korean multicenter study
by: Hyo-Cheol Kim, et al.
Published: (2023-01-01)

Successful Yttrium-90 Microsphere Radioembolization for Hepatic Metastases of Prostate Cancer
by: Alexander C. Bunck, et al.
Published: (2017-07-01)

Cholecystitis after yttrium-90 resin microsphere radioembolization treatment: Clinical and pathologic findings
by: Sagun Parakh, et al.
Published: (2016-07-01)

Efficacy and safety of guidewireless catheterization with a steerable microcatheter in patients scheduled for yttrium-90 radioembolization: a prospective multicenter trial
by: Zbigniew Serafin, et al.
Published: (2020-01-01)

Trans-arterial 90yttrium radioembolization for patients with unresectable tumors originating from the biliary tree
by: Joost W. Wijlemans, et al.
Published: (2011-07-01)

Prediction of hepatocellular carcinoma response to 90Yttrium radioembolization using volumetric ADC histogram quantification: preliminary results
by: Sonja Gordic, et al.
Published: (2019-05-01)

Beyond hepatocellular carcinoma and colorectal metastasis: The expanding applications of radioembolization
by: Omar eZurkiya, et al.
Published: (2014-06-01)

Standardizing SPECT/CT dosimetry following radioembolization with yttrium-90 microspheres
by: S. Peter Kim, et al.
Published: (2021-10-01)

Yttrium-90 Radioembolization of Hepatic Metastases from Colorectal Cancer
by: Raval eMihir, et al.
Published: (2014-07-01)

Precision dosimetry in yttrium-90 radioembolization through CT imaging of radiopaque microspheres in a rabbit liver model
by: E. Courtney Henry, et al.
Published: (2022-03-01)

Yttrium-90 radioembolization in desmoplastic small round cell tumor with recurrent hepatic metastasis following hyperthermic intraperitoneal chemotherapy
by: Harkanwar Gill, MD, et al.
Published: (2021-06-01)

Hepatic Abscess following Yttrium-90 Radioembolization in Patients with Surgical Bilioenteric Anastomosis or Compromised Sphincter of Oddi: A Tertiary Cancer Center Experience
by: Kevin N. Agahi, et al.
Published: (2022-09-01)

Inter-observer variability of 90Y PET/CT dosimetry in hepatocellular carcinoma after glass microspheres transarterial radioembolization
by: Nicolas Meyers, et al.
Published: (2020-05-01)

Multi institutional quantitative phantom study of yttrium-90 PET in PET/MRI: the MR-QUEST study
by: Nichole M. Maughan, et al.
Published: (2018-04-01)

Antireflux catheter improves tumor targeting in liver radioembolization with resin microspheres
by: Philippe d’Abadie, et al.
Published: (2021-11-01)

A Comparison of Techniques for 90Y PET/CT Image-Based Dosimetry following Radioembolization with Resin Microspheres
by: Alexander Samuel Pasciak, et al.
Published: (2014-05-01)

De Pierre Le Vénérable À Eudes De Châteauroux: La Réception Du Talmud, Entre Hostilité Et Incompréhension
by: Lecousy Amélia
Published: (2020-08-01)

Outcome and Safety after 103 Radioembolizations with Yttrium-90 Resin Microspheres in 73 Patients with Unresectable Intrahepatic Cholangiocarcinoma—An Evaluation of Predictors
by: Karolin J. Paprottka, et al.
Published: (2021-10-01)

A systematic review on the safety and effectiveness of yttrium-90 radioembolization for hepatocellular carcinoma with portal vein tumor thrombosis
by: Zhongzhi Jia, et al.
Published: (2016-01-01)

Current status of yttrium-90 microspheres radioembolization in primary and metastatic liver cancer
by: Yasaman Anbari, et al.
Published: (2023-11-01)

Optimal design of Anger camera for bremsstrahlung imaging: Monte Carlo evaluation.
by: Stephan eWalrand, et al.
Published: (2014-06-01)

Transarterial Yttrium-90 Radioembolization in Intrahepatic Cholangiocarcinoma Patients: Outcome Assessment Applying a Prognostic Score
by: Imke Schatka, et al.
Published: (2022-10-01)

Radioembolization for the treatment of hepatocellular carcinoma
by: Hyo-Cheol Kim
Published: (2017-06-01)

Yttrium-90 transarterial radioembolization versus conventional transarterial chemoembolization for patients with hepatocellular carcinoma: a systematic review and meta-analysis
by: Yi Yang, et al.
Published: (2018-09-01)

Phantom validation of quantitative Y-90 PET/CT-based dosimetry in liver radioembolization
by: Marco D’Arienzo, et al.
Published: (2017-11-01)

Prediction of survival according to kinetic changes of cytokines and hepatitis status following radioembolization with yttrium-90 microspheres
by: Chien-An Liu, et al.
Published: (2021-04-01)

Efficacy and Safety of Trans-Arterial Yttrium-90 Radioembolization in Patients with Unresectable Liver-Dominant Metastatic or Primary Hepatic Soft Tissue Sarcomas
by: Stefano Testa, et al.
Published: (2022-01-01)

Liver Resection and Transplantation Following Yttrium-90 Radioembolization for Primary Malignant Liver Tumors: A 15-Year Single-Center Experience
by: Daniel Aliseda, et al.
Published: (2023-01-01)

Safety and Efficacy of Concurrent Atezolizumab/Bevacizumab or Nivolumab Combination Therapy with Yttrium-90 Radioembolization of Advanced Unresectable Hepatocellular Carcinoma
by: Alexander Villalobos, et al.
Published: (2023-11-01)

Non-target activity detection by post-radioembolization yttrium-90 PET/CT: Image assessment technique and case examples
by: Yung Hsiang eKao, et al.
Published: (2014-02-01)